Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
464-05-012 ISMRM Abstract

The role of pelvic magnetic resonance imaging in pretreatment staging of patients with cervical cancer

Primary: Body - Uterus
Secondary: Diffusion
464-05-012 · MR-Based Quantitative Image and Image Processing · Tuesday, 12 May, 4:00 PM–4:55 PM · Digital Posters Row E
Keywords: Cervical cancer Clinical FIGO staging MRI FIGO staging.
Accepted
Jonas M Masaka 1, Lilian Salingwa1, Anganile Kalinga2, Amie Lee, Helena Machibya1
1Department of Radiology and Imaging, Muhimbili University of Health and Allied sciences, Dar Es Salaam, Tanzania
2Department of Radiology and Imaging, Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Presenting Author: Jonas M Masaka

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–49.
2. Republic U. United Republic of Tanzania. Popul Policy Compend. 1980;1–6.
3. Choi S, Ismail A, Pappas-Gogos G, Boussios S. HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK. Pathogens. 2023 Feb 11;12(2):298.
4. Bermudez A, Bhatla N, Leung E. Cancer of the cervix uteri. International Journal of Gynecology and Obstetrics. 2015 Oct 1;131:S88–95.
5. Bourgioti C, Chatoupis K, Moulopoulos LA. Current imaging strategies for the evaluation of uterine cervical cancer. World J Radiol. 2016;8(4):342.
6. Dhoot NM, Kumar V, Shinagare A, Kataki AC, Barmon D, Bhuyan U. Evaluation of carcinoma cervix using magnetic resonance imaging: Correlation with clinical FIGO staging and impact on management. J Med Imaging Radiat Oncol. 2012 Feb;56(1):58–65.
7. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. International Journal of Gynecology and Obstetrics. 2021 Oct 1;155(S1):28–44.
8. Bermudez A, Bhatla N, Leung E. Cancer of the cervix uteri. International Journal of Gynecology and Obstetrics. 2015 Oct 1;131:S88–95.
9. Manganaro L, Lakhman Y, Bharwani N, Gui B, Gigli S, Vinci V, et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018. Eur Radiol. 2021;31:7802–16.
10. Republic U. United Republic of Tanzania. Popul Policy Compend. 1980;1–6.
11. Nassali MN, Tadele M, Nkuba RM, Modimowame J, Enyeribe I, Katse E. Predictors of Locally Advanced Disease at Presentation and Clinical Outcomes Among Cervical Cancer Patients Admitted at a Tertiary Hospital in Botswana. International Journal of Gynecological Cancer. 2018 Jul;28(6):1218–25.
12. Balleyguier C, Sala E, Da Cunha T, Bergman A, Brkljacic B, Danza F, et al. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol. 2011 May;21(5):1102–10
13. QIN Y, PENG Z, LOU J, LIU H, DENG F, ZHENG Y. Discrepancies between clinical staging and pathological findings of operable cervical carcinoma with stage IB–IIB: A retrospective analysis of 818 patients. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2009 Oct;49(5):542–4.
14. Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro Faria S, Bhosale P. Cervical cancer: 2018 revised international federation of Gynecology and Obstetrics staging system and the role of imaging. Vol. 214, American Journal of Roentgenology. American Roentgen Ray Society; 2020. p. 1182–95.
15. Mwaka AD, Garimoi CO, Were EM, Roland M, Wabinga H, Lyratzopoulos G. Social , demographic and healthcare factors associated with stage at diagnosis of cervical cancer : cross-sectional study in a tertiary hospital in Northern Uganda. 2016;1–9.
16. Shahmoradi Z, Damgacioglu H, Clarke MA, Wentzensen N, Montealegre J, Sonawane K, et al. Cervical Cancer Incidence Among US Women, 2001-2019. JAMA. 2022 Dec;328(22):2267.
17. Gyamfua AA, Nkrumah I, Ibitoye BM, Agyemang BA, Ofosu ES, Tsoka-Gwegweni JM, et al. The level of knowledge and associated socio-demographic factors on cervical cancer among women: a cross-sectional study at Kenyase Bosore community, Ghana. Pan African Medical Journal. 2019 Sep;34
18. Mwaka AD, Garimoi CO, Were EM, Roland M, Wabinga H, Lyratzopoulos G. Social , demographic and healthcare factors associated with stage at diagnosis of cervical cancer : cross-sectional study in a tertiary hospital in Northern Uganda. 2016;1–9.
19. Lyimo FS, Beran TN. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: Three public policy implications. BMC Public Health [Internet]. 2012;12(1):22. Available from: http://www.biomedcentral.com/1471-2458/12/22
20. Kahesa C, Kjaer S, Mwaiselage J, Ngoma T, Tersbol B, Dartell M, et al. Determinants of acceptance of cervical cancer screening in Dar es Salaam, Tanzania. BMC Public Health [Internet]. 2012 Dec 19;12:1093. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23253445 [pmid]
21. Gutusa F, Roets L. Early cervical cancer screening: The influence of culture and religion. Afr J Prim Health Care Fam Med [Internet]. 2023 Jan 25;15(1):e1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36744462 [pmid]
22. Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer. Br J Cancer. 2003 Dec 25;89(11):2078–86.
23. Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F, et al. High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case–control studies. Women’s Health. 2022 Jan 4;18.
24. Lyimo FS, Beran TN. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: Three public policy implications. BMC Public Health. 2012 Dec 10;12(1):22.
25. Knoth J, Pötter R, Jürgenliemk-Schulz IM, Haie-Meder C, Fokdal L, Sturdza A, et al. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study. Gynecol Oncol. 2020 Oct 1;159(1):136–41

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/464-05-012